Cannabis Bioscience International Holdings (CBIH) Gross Profit (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Gross Profit across 5 years of filings, most recently posting $8160.0 for Q1 2026.

• Gross Profit for Q1 2026 came in at $8160.0, up 282.75% year-over-year; the trailing twelve-month figure through Feb 2026 was $97394.0 (down 67.37% YoY), and the FY2025 annual result was $262916.0, up 29.36% from the prior year.
• Gross Profit came in at $8160.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from $42766.0 in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $170525.0 in Q3 2024 to a low of -$4465.0 in Q1 2025.
• The 5-year median for Gross Profit is $36588.5 (2025), against an average of $47583.6.
• Across the five-year window, Gross Profit tumbled 118.15% in 2025 and surged 282.75% in 2026, its largest moves.
• Cannabis Bioscience International Holdings' Gross Profit stood at $75491.0 in 2022, then slumped by 35.55% to $48656.0 in 2023, then soared by 36.56% to $66445.0 in 2024, then plunged by 35.64% to $42766.0 in 2025, then plunged by 80.92% to $8160.0 in 2026.
• The last three Gross Profit figures came in at $8160.0 (Q1 2026), $42766.0 (Q4 2025), and $16057.0 (Q3 2025), per Business Quant data.